The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians
Abstract
BACKGROUND: Pharmacologic interventions are often prescribed for insomnia disorder. PURPOSE: To assess the benefits, harms, and comparative effectiveness of pharmacologic treatments for adults with insomnia disorder. DATA SOURCES: Several electronic databases (2004-September 2015), reference lists, and U.S. Food and Drug Administration (FDA) documents. STUDY SELECTION: 35 randomized, controlled trials of at least 4 weeks' duration that evaluated pharmacotherapies available in the United States and that reported global or sleep outcomes; 11 long-term observational studies that reported harm information; FDA review data for nonbenzodiazepine hypnotics and orexin receptor antagonists; and product labels for all agents. DATA EXTRACTION: Data extraction by single investigator confirmed by a second reviewer; dual-investigator assessment of risk of bias; consensus determination of strength of evidence. DATA SYNTHESIS: Eszopiclone, zolpidem, and suvorexant improved short-term global and sleep outcomes compared with placebo, although absolute effect sizes were small (low- to moderate-strength evidence). Evidence for benzodiazepine hypnotics, melatonin agonists, and antidepressants, and for most pharmacologic interventions in older adults, was insufficient or low strength. Evidence was also insufficient to compare efficacy within or across pharmacotherapy classes or versus behavioral therapy. Harms evidence reported in trials was judged insufficient or low strength; observational studies suggested that use of hypnotics for insomnia was associated with increased risk for dementia, fractures, and major injury. The FDA documents reported that most pharmacotherapies had risks for cognitive and behavioral changes, including driving impairment, and other adverse effects, and they advised dose reduction in women and in older adults. LIMITATIONS: Most trials were small and short term and enrolled individuals meeting stringent criteria. Minimum important differences in outcomes were often not established or reported. Data were scant for many treatments. CONCLUSION: Eszopiclone, zolpidem, and suvorexant may improve short-term global and sleep outcomes for adults with insomnia disorder, but the comparative effectiveness and long-term efficacy of pharmacotherapies for insomnia are not known. Pharmacotherapies for insomnia may cause cognitive and behavioral changes and may be associated with infrequent but serious harms. PRIMARY FUNDING SOURCE: Agency for Healthcare Research and Quality. ( PROSPERO: CRD42014009908).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults
Schutte-Rodin, S., Broch, L., Buysse, D., Dorsey, C., & Sateia, M. (2008) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27286 · Cited by 1,943
DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, FIFTH EDITION
Abbas, A., & Aminoroaia, M. (2013) · Cited by 1,479
Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits
Glass, J., Lanctôt, K. L., Herrmann, N., Sproule, B. A., & Busto, U. E. (2005) · BMJ · doi:10.1136/bmj.38623.768588.47 · Cited by 1,161
Behavioral and Pharmacological Therapies for Late-Life Insomnia: A Randomized Controlled Trial
Morin, C. M., Colecchi, C., Stone, J., Sood, R., & Brink, D. (1999) · JAMA · doi:10.1001/jama.281.11.991 · Cited by 1,095
Morin, C. M., & Benca, R. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60750-2 · Cited by 976
Morin, C. M., Vallières, A., Guay, B., Ivers, H., Savard, J., Mérette, C., Bastien, C., & Baillargeon, L. (2009) · JAMA · doi:10.1001/jama.2009.682 · Cited by 791
National Institutes of Health State of the Science Conference Statement
(2005) · Sleep · doi:10.1093/sleep/28.9.1049 · Cited by 745
Krystal, A. D., Walsh, J. K., Laska, E., Caron, J., Amato, D. A., Wessel, T. C., & Roth, T. (2003) · Sleep · doi:10.1093/sleep/26.7.793 · Cited by 630
Meta-analysis of benzodiazepine use in the treatment of insomnia.
(2000) · PubMed Central · Cited by 613
Jacobs, G. D., Pace-Schott, E. F., Stickgold, R., & Otto, M. W. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.17.1888 · Cited by 579
Insomnia and health-related quality of life
Kyle, S. D., Morgan, K., & Espie, C. A. (2010) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2009.07.004 · Cited by 520
Michelson, D., Snyder, E., Paradis, E., Chengan-Liu, M., Snavely, D. B., Hutzelmann, J., Walsh, J. K., Krystal, A. D., Benca, R. M., Cohn, M., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70053-5 · Cited by 519
Hypnotics' association with mortality or cancer: a matched cohort study
Kripke, D. F., Langer, R. D., & Kline, L. E. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-000850 · Cited by 408
Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials
Herring, W. J., Connor, K. M., Ivgy-May, N., Snyder, E., Liu, K., Snavely, D. B., Krystal, A. D., Walsh, J. K., Benca, R. M., Rosenberg, R., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.10.003 · Cited by 300
Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia
Zammit, G. K., McNabb, L. J., Caron, J., Amato, D. A., & Roth, T. (2004) · Current Medical Research and Opinion · doi:10.1185/174234304x15174 · Cited by 294
Zolpidem Use and Hip Fractures in Older People
Wang, P. S., Bohn, R. L., Glynn, R. J., Mogun, H., & Avorn, J. (2001) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2001.49280.x · Cited by 272
Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia
Roth, T., Seiden, D., Sainati, S., Wang-Weigand, S., Zhang, J., & Zee, P. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2006.01.003 · Cited by 265
Weich, S., Pearce, H. L., Croft, P., Singh, S., Crome, I., Bashford, J., & Frisher, M. (2014) · BMJ · doi:10.1136/bmj.g1996 · Cited by 259
Walsh, J. K., Krystal, A. D., Amato, D. A., Rubens, R., Caron, J., Wessel, T. C., Schaefer, K., Roach, J., Wallenstein, G., & Roth, T. (2007) · Sleep · doi:10.1093/sleep/30.8.959 · Cited by 239
Cognitive behavioural interventions for sleep problems in adults aged 60+
Montgomery, P., & Dennis, J. A. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003161 · Cited by 231
ROTH, T., WALSH, J., KRYSTAL, A., WESSEL, T., & ROEHRS, T. (2005) · Sleep Medicine · doi:10.1016/j.sleep.2005.06.004 · Cited by 230
A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
Scharf, M. B., Roth, T. G., Vogel, G. W., & Walsh, J. K. (1994) · PubMed · Cited by 223
Krystal, A. D., Erman, M., Zammit, G. K., Soubrane, C., & Roth, T. (2008) · Sleep · doi:10.1093/sleep/31.1.79 · Cited by 212
Hajak, G., Rodenbeck, A., Voderholzer, U., Riemann, D., Cohrs, S., Hohagen, F., Berger, M., & Ruther, E. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0609 · Cited by 199
Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis
Kuriyama, A., Honda, M., & Hayashino, Y. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2013.11.788 · Cited by 198
Evaluation of the Efficacy and Safety of Ramelteon in Subjects with Chronic Insomnia
Zammit, G., Erman, M., Wang-Weigand, S., Sainati, S., Zhang, J., & Roth, T. (2007) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.26914 · Cited by 197
Krystal, A. D., Durrence, H. H., Scharf, M., Jochelson, P., Rogowski, R., Ludington, E., & Roth, T. (2010) · Sleep · doi:10.1093/sleep/33.11.1553 · Cited by 193
Elie, R., Ruther, E., Farr, I., Emilien, G., Salinas, E., & The Zaleplon Clinical Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0806 · Cited by 191
Wade, A. G., Ford, I., Crawford, G., McConnachie, A., Nir, T., Laudon, M., & Zisapel, N. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-51 · Cited by 178
Chen, P.-L., Lee, W.-J., Sun, W.-Z., Oyang, Y.-J., & Fuh, J.-L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049113 · Cited by 177
Mayer, G., Wang-Weigand, G., Roth‐Schechter, B. F., Lehmann, R., Staner, C., & Partinen, M. (2009) · SLEEP · doi:10.1093/sleep/32.3.351 · Cited by 165
Brasure, M., Fuchs, E. L., MacDonald, R. H., Nelson, V. A., Koffel, E., Olson, C. M., Khawaja, I. S., Diem, S. J., Carlyle, M. H., Wilt, T. J., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1782 · Cited by 161
Self-citationLong-term use of sedative hypnotics in older patients with insomnia
Ancoli-Israel, S., Richardson, G. S., Mangano, R. M., Jenkins, L., Hall, P., & Jones, W. S. (2005) · Sleep Medicine · doi:10.1016/j.sleep.2004.10.015 · Cited by 154
Long-Term, Non-Nightly Administration of Zolpidem in the Treatment of Patients With Primary Insomnia
Perlis, M. L., McCall, W. V., Krystal, A. D., & Walsh, J. K. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0816 · Cited by 144
Krystal, A. D., Lankford, A., Durrence, H. H., Ludington, E. A., Jochelson, P., Rogowski, R., & Roth, T. G. (2011) · SLEEP · doi:10.5665/sleep.1294 · Cited by 141
Wade, A. G., Crawford, G. M., Ford, I., McConnachie, A., Nir, T., Laudon, M., & Zisapel, N. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.537317 · Cited by 129
Wu, R., Bao, J., Zhang, C., Deng, J., & Long, C. (2006) · Psychotherapy and Psychosomatics · doi:10.1159/000092892 · Cited by 120
Greater incidence of depression with hypnotic use than with placebo
Kripke, D. F. (2007) · BMC Psychiatry · doi:10.1186/1471-244x-7-42 · Cited by 107
Zolpidem Use and Risk of Fracture in Elderly Insomnia Patients
Kang, D. Y., Park, S., Rhee, C.-W., Kim, Y., Choi, N., Lee, J., & Park, B. (2012) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.2012.45.4.219 · Cited by 106
Xu, M., Bélanger, L., Ivers, H., Guay, B., Zhang, J., & Morin, C. M. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2010.09.003 · Cited by 100
Benzodiazepine use and motor vehicle accidents. Systematic review of reported association.
Thomas, R. E. (1998) · PubMed · Cited by 97
Ancoli-lsrael, S., Krystal, A. D., McCall, W. V., Schaefer, K., Wilson, A., Claus, R., Rubens, R., & Roth, T. G. (2010) · SLEEP · doi:10.1093/sleep/33.2.225 · Cited by 96
Efficacy of Eight Months of Nightly Zolpidem: A Prospective Placebo-Controlled Study
Randall, S., Roehrs, T., & Roth, T. G. (2012) · SLEEP · doi:10.5665/sleep.2208 · Cited by 93
Zaleplon improves sleep without producing rebound effects in outpatients with insomnia
Fry, J. M., Scharf, M. B., Mangano, R. M., & Fujimori, M. (2000) · International Clinical Psychopharmacology · doi:10.1097/00004850-200015030-00003 · Cited by 93
Lankford, A., Rogowski, R., Essink, B., Ludington, E. A., Durrence, H. H., & Roth, T. G. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2011.09.006 · Cited by 92
Schlich, D., LʼHéritier, C., Jp, C., & Attali, P. (1991) · Journal of International Medical Research · doi:10.1177/030006059101900313 · Cited by 80
Hypnotics and mortality in an elderly general population: a 12-year prospective study
Jaussent, I., Ancelin, M., Berr, C., Pérès, K., Scali, J., Besset, A., Ritchie, K. A., & Dauvilliers, Y. A. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-212 · Cited by 78
Meta-Analyses of Hypnotics and Infections: Eszopiclone, Ramelteon, Zaleplon, and Zolpidem
Joya, F. L., Kripke, D. F., Loving, R. T., Dawson, A., & Kline, L. E. (2009) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27552 · Cited by 62
Rybarczyk, B. D., Lund, H. G., Shamaskin‐Garroway, A., & Mack, L. (2012) · Clinical Gerontologist · doi:10.1080/07317115.2012.731478 · Cited by 62
Long-term use of zolpidem increases the risk of major injury: a population-based cohort study
Lai, M.-M., Lin, C.-C., Lin, C.-C., Liu, C.-S., Li, T.-C., & Kao, C.-H. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.01.021 · Cited by 58
Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study
Voshaar, R. C. O., van Balkom, A. J. L. M., & Zitman, F. G. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.09.007 · Cited by 55
Richardson, G. S., Zammit, G. K., Wang‐Weigand, S., & Zhang, J. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.07m03834 · Cited by 54
Roth, T. G., Krystal, A. D., Steinberg, F. J., Singh, N., & Moline, M. L. (2013) · SLEEP · doi:10.5665/sleep.2370 · Cited by 48
Possibility that certain hypnotics might cause cancer in skin
KRIPKE, D. F. (2008) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2008.00685.x · Cited by 47
Allain, H., Arbus, L., & Sch??ck, S. (2001) · Clinical Drug Investigation · doi:10.2165/00044011-200121060-00001 · Cited by 32
Long-term safety and efficacy of ramelteon in Japanese patients with chronic insomnia
Uchiyama, M., Hamamura, M., Kuwano, T., Nagata, H., Hashimoto, T., Ogawa, A., & Uchimura, N. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2010.10.006 · Cited by 32
Lahmeyer, H. W., Wilcox, C. S., Kann, J., & Leppik, I. E. (1997) · Clinical Drug Investigation · doi:10.2165/00044011-199713030-00003 · Cited by 30
Uchimura, N., Ogawa, A., Hamamura, M., Hashimoto, T., Nagata, H., & Uchiyama, M. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.197 · Cited by 27
Long-term, Non-nightly Administration of Zolpidem in the Treatment of Patients With Primary Insomnia
Ballenger, J. (2006) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)70258-5 · Cited by 21
Zolpidem “as needed” for the treatment of primary insomnia: A double-blind, placebo-controlled study
Walsh, J. K. (2002) · Sleep Medicine Reviews · doi:10.1016/s1087-0792(02)80002-8 · Cited by 13
Brioni, J. D., Kim, D. J. B., O'Neill, A. B., Brodie, M. S., Decker, M. W., & Arnerić, S. P. (1997) · Drug Development Research · doi:10.1002/(sici)1098-2299(199703)40:3<230::aid-ddr3>3.0.co;2-l · Cited by 3
Research works printed but not linked: 4
- Montgomery P, 2003, Cochrane Database Syst Rev, CD003161
- Scharf MB, 1994, J Clin Psychiatry, 55, 192
- Holbrook AM, 2000, CMAJ, 162, 225
- Thomas RE, 1998, Can Fam Physician, 44, 799
Cited by
Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., Denberg, T. D., & for the Clinical Guidelines Committee of the American College of Physicians* (2016) · Annals of Internal Medicine · doi:10.7326/m15-2175 · Cited by 1,965
Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6470 · Cited by 1,519
Melatonin as a Hormone: New Physiological and Clinical Insights
Cipolla-Neto, J., & Amaral, F. G. D. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00084 · Cited by 635
Sleep and anxiety: From mechanisms to interventions
Chellappa, S. L., & Aeschbach, D. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101583 · Cited by 509
De Crescenzo, F., D'Alò, G. L., Ostinelli, E. G., Ciabattini, M., Di Franco, V., Watanabe, N., Kurtulmus, A., Tomlinson, A., Mitrova, Z., Foti, F., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00878-9 · Cited by 446
Metadata
- Authors
- Wilt, T. J., MacDonald, R., Brasure, M., Olson, C. M., Carlyle, M., Fuchs, E., Khawaja, I. S., Diem, S., Koffel, E., Ouellette, J., Butler, M., & Kane, R. L.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2016-07-19
- Volume
- 165
- Issue
- 2
- Pages
- 103-112
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2346896034
- Cited by
- 275
- References
- 63
- FWCI
- 42.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Funders
- Agency for Healthcare Research and Quality (HHSA 290-2012-00016-I)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.